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The classical class I major transplantation antigens play an essential role in the
recognitionofantigenbyCTL. Theirextremepolymorphism is presumably central
to their function in binding peptide derivatives of rapidly evolving intracellular
pathogens. All the evidence to datehas indicated that this functionalpolymorphism
depends solely on primary sequence polymorphism in class I H chain genes. First,
such genes, and their protein products, are extensively polymorphic, especially in
the al and a2 domains (1). Second, classical genetic experiments demonstrate that
functional polymorphism ofclass I molecules segregates accurately with class I loci
(2-5). Third, it has been shown repeatedly that the normal polymorphic structure
offunctional class I molecules can be reconstituted in cells by transfection ofclass
I H chain genes alone (6, 7). Finally, functional polymorphism defined by the ac-
tivity ofalloreactiveor MHC-restricted Tcells hasbeenreferred explicitly topartic-
ularaminoacid residues coded inthe al and0domainsofthe Hchain that appear
to encircle the putative peptide-binding site (8).
In this study we report an exception to these general observations. We find that
the alloantigenic structure of the product ofthe classical class I locus ofthe rat can
be changed significantly by the action of a gene located elsewhere within the rat
MHC. These structural changes are especially conspicuous at the level ofprimary
alloreactive and secondary MHC-restricted cytotoxic T cells, but can also be de-
tected with a monoclonal alloantibody.
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The rat MHC, RT1, has been divided by recombination into several functionally
distinct regions (Fig. 1) (9, 10). The RTLA region codes for the H chain of classical
class I molecules equivalent to mouse H-2K, -D, and -L. In terms of location in
the MHC, RT1.A seems to be most closely related to mouse H-2K. RTLA class
I molecules are strong transplantation antigens, restrict cytotoxic T cell responses
against viruses and minor histocompatibility antigens, induce potent alloantibody
responses, and stimulate strong primary cytotoxic T cell responses in vitro. The ad-
jacent class II region has been split into three subregions: RTLB and RTLD coding
for molecules homologous to H-2 I-A and I-E, respectively (11, 12), and RTI.H con-
taining DNA sequences that crosshybridize with human DP probes (13). The RTLE
and RTLC regions contain the majority of rat class I genes, and specify a number
ofclass I alloantigens with properties generally reminiscent ofmedial histocompati-
bility antigens of the Qa and Tla regions of the mouse MHC (14-18).
The present experiments show that the RTLA classical class I molecules of the
RTla haplotype are subject to structural modification by the trans-acting product
of a new locus, cim, mapping to the right of the RT1.A/RT1.B recombination site.
Strains carrying RTLAa and the dominant cim allele express RTLAa class I mole-
cules that are antigenically distinct from those expressed in strains where the domi-
nant cim allele has been lost by recombination . That the modifying locus acts in
trans can be demonstrated by reconstitution of the dominant antigenic phenotype
in appropriate F, hybrids. Biochemical analysis shows that the modifier has a
marked influence on the post-translational processing of RT1 .Aa. The results are
discussed in terms of the possible mode of action of this novel MHC-linked locus.
Materials and Methods
Animals.
￿
Rats were bred in the conventional animal colony in the Immunology Depart-
ment, AFRO Institute ofAnimal Physiology and Genetics Research, Babraham, Cambridge,
UK, or were obtained from OLAC 76 Ltd., Shaw's Farm, Bicester, Oxon, UK. The MHC
haplotypes ofthe strains used in this study are given in Table I, where we also indicate the
abbreviated strain names used in the text.
Immunizations.
￿
Female rats were immunized against the rat male antigen H-Y by a single
injection of syngeneic male lymphoid cells. Spleens from male rats were prepared as a cell
suspension in PBS, washed once, and resuspended in 10 ml PBS. Each female rat received
1 ml ofthis cell suspension: 0.1 ml injected subcutaneously at five sites (twice at the shoulders,
twice at the flanks, and once at the base oftail), and 0.5 ml into the peritoneal cavity. Lymph
node cells from primed rats were boosted with male cells in vitro at least 3 wk after immuni-
zation before being assayed for cytolytic activity.
Media.
￿
Cells were prepared and washed in RPMI-Hepes (RPMI 1640, Flow Laboratc
ries, Irvine, UK, buffered with 2 .5 mM Hepes (Sigma Chemical Co., St. Louis, MO), sup-
plemented with 5% FCS (Sera-Lab, Crawley Down, Sussex, UK) for cells to be set up in
culture, orwith 10% Haemaccel (Veterinary grade; Hoechst UK Ltd., Hounslow, Middlesex,
UK) for washing effector and target cells in cell-mediated cytotoxicity assays. Cells were cul-
tured in complete medium : RPMI 1640 plus 5% FCS, 2.5 x 10-5 M 2-ME, 2 MM L-gluta-
mine, 100 U/ml penicillin, and 100 Ag/ml streptomycin. Cultures were incubated at 37°C
in a humidified atmosphere of 5o7o C02 in air.
ConA Supernatant (CAST.
￿
Pooled spleen and lymph node cells from female PVG rats were
cultured at 2.5 x 106 cells/ml in complete medium containing 2.5 Rg/ml Con A (Sigma
Chemical Co.). After 40-44 h, the supernatant was decanted, centrifuged at 800 g for 10 min,
then at 2,000 g for 30 min, sterilized by passage through an 0.22-w filter (Millipore Con-
tinental Water Systems, Bedford, MA), and stored at -20°C.
mAbs.
￿
Three mAbs specific for the RT1.Aa class I molecule were used in this study.LIVINGSTONE ET AL.
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R2/15S, R3/13, and JY3/84 are rat alloantibodies obtained from AO anti DA (RT1 ° anti-
RT1a) immunizations. They bind at three distinct sites, designated S, P, and T, respectively,
on the RTLAa molecule (20). R2115S and JY3/84 are both IgG2a antibodies, while R3/13
is an IgG2b antibody. The R2/15S preparation used to block T cell-mediated cytotoxicity
was purified by ammonium sulphate precipitation from 20-fold-concentrated serum-free culture
supernatant. It was dialyzed extensively against PBS and then against RPMI-Hepes before
use. Tissue culture supernatants of R2/15S and JY3/84 were used as first-stage antibodies
for RIA.
Cytotoxic TCells.
￿
Cytotoxic responses against MHC alloantigens were generated in pri-
mary MLC. Unprimed responder cells (lymph node or thoracic duct lymphocytes) were cul-
tured with 3,300-rad gamma-irradiated (137Cs source, Gammacell 40; Atomic Energy of
Canada, Ottawa) stimulator cells (lymph node cells, or a mixture oflymph node plus spleen
cells) in 200 jiI medium in round-bottomed microtiter plates. Cells were incubated for 5 d,
harvested, and assayed for cytotoxic activity. CTL specific for the rat male antigen H-Y were
generated by the restimulation of lymph node cells from primed female rats. 105 responder
lymphocytes were cultured with 3 x 105 irradiated (3,000 rad) male lymph node cells in 200
Al in round-bottomed microtiter wells as described above, harvested on day 5, and assayed.
In many experiments, 25% CAS plus 50 mM cx-methyl mannoside to prevent nonspecific
T cell activation was added to the culture medium.
Targets.
￿
Lymph node cells from normal rats were cultured at 2.5 x 106 cells/ml in me-
dium plus 2.5 gg/ml Con A. Blasts were harvested after 24-28 h, centrifuged at 200 g for
3 min, and the supernatant was discarded. Sodium 5'Cr-chromate in aqueous solution
(CJS4, The Radiochemical Centre, Amersham, Bucks, UK), equivalent to 50 JACi, was added
to the pelleted cells, which were then flicked into suspension. Targets were labeled for 1-4 h
om temperature, washed twice in RPMI-Hepes + 10% Haemaccel, resuspended in
I-Hepes + FCS, and counted.
Cell-mediated Lympholysis Assay (CML).
￿
Effector cells were harvested from MLC on day
5, pelleted by centrifugation at 200 g for 5 min, resuspended in RPMI-Hepes + 10% FCS,
and counted by trypan blue dye exclusion. They were then made up to an appropriate con-
centration and serial threefold dilutions were made. 100 JAI effector cells plus 100 A1 5'Cr-
labeled target cells (105 cells/ml) were dispensed into round-bottomed microtiter wells; con-
trol wellsfor determining spontaneous release values received 100 ld targetsplus 100 lal medium.
Effector and target cells were mixed thoroughly and centrifuged (65 g for 2 min). The plates
were incubated for 4 h at 37°C in a humidified atmosphere of 5% COz in air. 1001x1 super-
natant was harvested from each well and counted in a gamma scintillation counter. Lysis
calculated according to the formula: percent cytotoxicity = 100 x (experimental counts
- spontaneous release)/(total input counts - spontaneous release). Input counts were de-
termined with appropriate aliquots ofthe target cell suspension. Spontaneous release values
were generally 10-20% of total input counts. SDs of replicate wells are shown when >3 17o
of the mean.
Cold Target Competition.
￿
Unlabeled (cold) Con A blasts were made up to 2 x 107 cells/ml
in RPMI/Hepes + 10% FCS. Two further threefold dilutions were usually made, to give
final cold/hot target ratios of 100:1, 33:1, and 11 :1 in the assay. 50 EA cold targets, 50 Al 5'Cr-
labeled targets (at 2 x 105 cells/ml), and 100 lil effector cells (or 100 Al medium in sponta-
neous release wells) were dispensed in that order into microtiter wells, mixed, centrifuged,
incubated, and harvested as described above.
Inhibition ofLysisby mAbs,
￿
Serial fivefold dilutions of antibody from an initial concentra-
tion of 100 Ftg/ml were made in RPMI-Hepes + 10% FCS. 50 ul antibody plus 50 JAI "Cr-
labeled target cells (2 x 105 cells/ml) were dispensed into microtiter wells and incubated at
room temperature for 30 min. 100 Al effector cells (or 100 Al medium in spontaneous release
wells) were then added, effector and target cells mixed, and the assay was incubated for a
further 4 h at 37'C before harvesting.
In many of the experiments in this study, the RTLA3 class I molecule was expressed on
both effector and target cell populations. It has been shown that antibody specific for class
I molecules expressed on both effector and target cells does not inhibit lysis(19). We confirmed
this by assaying (a x c)F, anti-AO CTL (specific for RTi° alloantigens) on AO (RT1u) and780
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(AO x DA)F, (RTILI x RTla) targets in the presence of the antibody R2/155. In neither case
was there any significant inhibition of lysis (data not shown).
RIA.
￿
The binding of mAbs R2/155 and JY3/84 to erythrocytes from various rat strains
and F, hybrids was determined in a two-stage RIA using 1251-rabbit anti-rat IgG(Fc) an-
tiserum at the second stage, as described elsewhere (20).
Two-dimensional Peptic Peptide Maps.
￿
Peptide mapping was performed on class I H chains
derived from Con A blasts surface iodinated using the lactoperoxidase method. The location
of the appropriate bands was determined by autoradiography of the frozen SDS polyacryl-
amide gels, after which the gel was sectioned, and the labeled material eluted. Subsequent
digestion with pepsin and separation of the peptides on silica gel thin layer elecrophoresis
followed by chromatography was as previously described (21, 22).
Pulse-chase Labeling and Immunoprecipitation.
￿
Con A blasts were labeled for 10 min with L-
[35S] methionine (Amersham International, Amersham, UK) after a 30-min preincubation
in methionine-free MEM (Gibco Laboratories, Paisley, UK). Incorporation was terminated
by washing and subsequent reincubation of the cells in DMEM containing a fivefold excess
ofunlabeled methionine. Aliquots ofcells were removed at the indicated post-pulse time points
and the cells immediately pelleted and lysed in 200 tcl lysisbuffer (2% NP-40, 20 mM Tris-
HCl, pH 8.0, 150 mM NaCl, 1 MM MgC12, 1 mM PMSF). The lysates were kept on ice
for 30 min, spun at 11,600g for 6 min to remove debris, and stored at -20°C until immuno-
precipitation. Cell lysates were precleared for 1 h at 4 0C with 20 gl (packed volume) ofSepharose
4B (Pharmacia Fine Chemicals, Uppsala, Sweden) coupled to an irrelevant rat mAb. RT1 .Aa
was then precipitated with 20 TAI ofR3/13 coupled to Sepharose 4B for 2 h at VC. The Sepharose
reagent was washed twice in buffer (0.5% NP-40, 0.1 M Tris-HCI, pH 8.0, 0.5 M NaCl,
10 mM EDTA) and boiled in 20 Al of SDS sample buffer (0.6 M Tris-HCI, pH 6.8, 2.3%
SDS, 5% 2-ME, 10% glycerol) for 2 min. Supernatants were analyzed by SDS-PAGE on
11 % gels. Gels were treated with Amplify (Amersham International), dried, and fluorographed
at -70GC.
Results
CTL Specific for RTLA° Detect a Reciprocal Antigenic Diference between Parental and
Recombinant Targets. The Aa class I molecule was the principal target for alloreac-
tive CTL populations raised against a full a haplotype incompatibility or against
an Aa difference alone (see Fig. 1 for MHC map and Table I for MHC haplotypes
of strains used in this study and for abbreviated strain names underscored in the
text). c anti-a CTL (a full a haplotype incompatibility) killed RI and R8 targets almost
as effectively as parental a targets, (Fig. 2 a), while c anti-RI CTL (an Aa difference
alone) killed all three target populations equally well (Fig. 2 b). The mAb R2/15S,
specific for the Aa class I molecule, blocked the lysis of _a, Rl, and R8 targets by
both CTL populations (Fig. 2, c and d), confirming this molecule as the principal
target antigen for these cytotoxic responses. While R2/15S completely blocked the
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A diagram representing the regions of the rat MHC, RTl, on chromosome 14 (23).
Most of the assignments are justified in published reviews (9, 10). The existence of a new class
II sub-region to the left of RTLB has been demonstrated recently (13). The proposed mapping
of class III genes is implied by a recent study on the localization of C4 (24).LIVINGSTONE ET AL.
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TABLE I
Rat Strains Used in this Study and their MHC Haplotyßes
" Abbreviated strain names have been used in the present text in the interests of clarity. Ab-
breviated strain names are underscored.
ï To be precise, the DA strain carries the variant aul haplotype and has differences from the
canonical a of the strain AVN, notably in the nonclassical class I genes ofthe C region. In
the interest of clarity, however, we have used the name a for the MHC haplotype of DA.
No AVN-derived rat strains were used in this study so no ambiguities arise.
S Congenic strains bearing two independent variant 1 haplotypes In?(AGUS) and IVI(F344).
II Strain now extinct.
lysis ofall appropriatetargets byçanti-RI CTL (Fig. 2d), andofRl and R8 targets
bySanti-a CTL (Fig. 2 c), it did not completely block the lysis ofparental a targets
byS anti-a CTL (Fig. 2 c), probably because asmallcomponentofthis response was
directed against antigens coded by the Ba, Da, or Ca regions (25).
Unexpectedly, when c anti-a CTL were assayed on "Cr-labeled parental a targets
in the presence of a haplotype (DA and _a) or recombinant (RI, R7 and R8) cold
targets, DA andparental a coldtargets blocked lysis about ninefold moreeffectively
than recombinant cold targets (Fig. 3 a). Cold target competition oflysis by ç anti-
R1 CTL gave the opposite pattern ofinhibition. R1, R7, and R8 cold targets were
about nine timesmore effective than either DAor parental acoldtargets at blocking
the lysis of51Cr-labeled targets by c anti-RI CTL (Fig. 3 b). The reciprocal char-
acter of these results suggested that there was a gain and loss antigenic difference
between the Aa class I molecules expressed on parental _a cells and those expressed
on cells from recombinant strains carrying only the Aa region ofthe a haplotype.
We next asked whether any such difference could be demonstrated with MHC-
restricted CTL. RTLAI class I molecules have been shown to restrict cytotoxic re-
sponses to the male antigen H-Y (18). Anti-HY CTL were therefore generated in
parental a and recombinantstrains, andassayed on a and recombinanttargets. Again,
weobserved adistinctionbetweenparental a_andrecombinanttargets, whichinthis
case was immediately apparent by direct cytotoxic assay. a anti-HYspecific CTL
killed a strain male targets better than R1 or R8 male targets, while Rl anti-HY
CTL killed Rl and R8 maletargets better than _astrain male targets (Fig. 4, a and b).
Both a anti-HY CTL and R1 anti-HY CTL were restricted by the Aa class I mol-
Strain
Abbreviated
strain name'
RTl
haplotype
Origin of
RTI region
A B/D C MHC
Independent Inbreds
AO - a u u u -
DA - a a a a -
PVG c c1 c c c -
MHC congenics
PVG-RTIa"'(DA) a a a a a DA
PVG-RTI"?(AGUS) _l(AGUS)5 1 I 1 1 AGUS
PVG-RTI"'(F344) _ I(F344)5 l 1 1 1 F344
PVG-RTI°(AO) _u a u u u AO
MHC recombinant congenics
PVG.RI R1 r1 a c c DA/PVG
PVG.R71 R7 r7 a c c DA/PVG
PVG.RS RS r8 a u u DA/AO782
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Alloreactive CTL
raised against a full RT1a in-
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RTI.Aa difference alone, are
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I molecule. canti-a CTL(anti-
ecule, since lysis ofall appropriate male targetswasblocked completely by the mAb
R2/15S (Fig. 4, c and d).
Parental a Cells Can Make an Aa-speck Cytotoxic Response Against Recombinant Stimu-
lators. We next asked whether an antigenic difference between the two forms of
RT1.Aa could be detected by direct immunization. Unprimed (c x a)FI lympho-
cyteswere cultured with Rl stimulator cells in MLC, and assayed 5 dlater forcyto-
lytic activity. This responder/stimulator combination (A`BcD'Cc x AaB'DaCa anti-
AaBcDcCc) was chosen to exclude conventional incompatibilities, leaving just thea
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FIGURE 3.
￿
Aa specific allore-
active CTLcandistinguish be-
tweenparental (a)and recombi-
nant (RI, R7, R8)cellsin cold
target competition assays. A
panelof unlabeled (cold) target
cells from various strains was
used to competeforthelysisof
51Cr-labeled _a targets(a') by c
anti-a CTL(a), andof 51Cr-la-
beledRl targets(Rl')by canti-
R1 CTL(b). Both CTL popu-
lationswere assayed at an E/T
ratio of 50:1 .
proposed difference between _a and recombinant forms of the As class I molecule.
CTL raised in this combination killed targets of all three recombinant strains (Fig.
5a), andthelysis ofR1 targetswascompletely blocked by R2/15S (Fig. 5 b), confirming
the existence of a "recombinant-specific" determinant associated with the Aa class
I molecule. R1, R7, and R8 cold targets all blocked the lysis of "Cr-labeled RI
targets by these CTL (Fig. 5 c), showing that the same antigenic determinant was
expressed by cells forall three recombinanthaplotypes. Responses of similar specificity
were subsequently generated in the combinations (a x u)Fi anti-R8 and (DA x
c)Fi anti-RI and in the combination (DA x AO)F, anti-R8, where there are also
minor histocompatibilities (data not shown). Targets ofthe responderparental strains
(i.e., a and c in Fig. 5 a) were not killed, and (c x a)Fi lymphocytes did not de-
velop any cytolytic activity when cultured with _a or c stimulators (datanot shown),
thus distinguishing the present findings from classical "F, antiparental" responses
(26, 27).
The lack ofappropriate recombinant strains made it impossible to generate CTL
in combinations where determinants on the parental a specific form of theAa mol-
ecule were the only known incompatibility. Weak CTL responses specific for these
determinants were obtained, however, when unprimed RI cellswere stimulated with
_a cells (Fig. 6). While a small component of this response may have been directed
against antigens encoded by the Ba, Da, and Ca regions, most of it was directed
against the As, molecule since the lysis of _a targets could be blocked effectively by
the mAb R2/15S (Fig. 6 b). This result confirmed that there was a reciprocal anti-
genic difference between parental a and recombinant forms of the As class I mole-784
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A'-restricted, H-Y-specific CTL distinguish between parental (a)and recombinant
(RI, R8)male targets. a and Rl female anti-male CTL were generated by immunisation with
syngeneic male cells followed by an in vitro stimulation. CTL were assayed on apanel of male
andfemale cells(a and b). The same CTL populations were assayed at one E/T ratio (30:1) on
_a, R1, andR8 male targets in thepresence ofthe A'-specific mAbR2/15S (c andd); control levels
of lysis without antibody are shown by open symbols.as
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Cellscarrying theparental RTla haplotype canmake a primary cytotoxic response
against the recombinant form of the Aa class I molecule. (c x a)FI anti-RI CTL generated in
primary MLC were assayed on a panel of target cells (a). Only targets carrying arecombinant
haplotype(filledsymbols) were killed. Theordinate in this panelexceptionallyrecords lysisas per-
cent of input counts for all targets due to a lost spontaneous release sample. CTL raised in the
same combination were assayed at one E/T ratio (30:1) on RI targetsin the presence oftheAa-
specific mAb R2/15S (b); the control level oflysis without antibody is shownby the open circle.
(c x a)F) anti-RI CTLwere also assayed at one E/T ratio (18:1) on 5'Cr-labeled RI targets in
the presence of unlabeled (cold) target competitors of parental and recombinant genotype (c).
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Recombinant cellscanmake aprimarycytotoxic response against the parental form
ofthe As classI molecule. RI anti-a CTL generated in primary MLC were assayed on apanel
of target cells (a). These CTL were also assayed at one E/T ratio (120:1) on parental a_ targets
in the presence of the As-specific mAb R2/15S (b); the control level of lysis without antibody
is shown by the dotted line.
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cule. From now on, the parental a form of this molecule will be called Aa+, and the
recombinant (RI, R7, R8) form Aa- . In a preliminary report (28) the two forms
were called Aa and Aa.
The Expression ofAal Is Determined by an Interaction between the RTI.Aa Region and a
trans-acting Gene Mapping to the RT1.Ba, RT1.Da, or RTI.C' Regions. Further experi-
ments used cells from the (a x Rl)Fl hybrid to distinguish between cis- and trans-
acting mechanisms responsible for the antigenicconsequences ofintra-MHC recom-
bination. A cis-acting mechanism, such as an intra-genic recombinational hotspot
(29), would result in these cells co-expressing heterozygous levels of Aa' and Aa-.
In fact, (a x R1)Fl cells were found to express no detectable Aa- and homozygous
levels of Aa+, consistent with a dominant trans-acting mechanism. Fig. 7 shows the
results of three different experimental approaches to ask whether (a x R1)F1 cells
expressed Aa-. These cells were tested as targets for (c x a)F1 anti-R1 CTL (Fig.
7 a); as cold target competitors of the lysis of "Cr-labeled R1 targets by these CTL
(Fig. 7 b); and forthe ability to stimulate (c x a)F1 responder cells in primary MLC
(Fig. 7 c). No Aa- was detected on these cells in any of the assays. In contrast, each
experiment showed that heterozygous levels of Aa- could be detected on (c x R1)Fj
cells, both as targets and as stimulators.
Evidence that (a x R1)Fl cells expressed high levels of Aa+ came from two
differentexperiments. First, in cold target competitionexperiments ofthe kind shown
in Fig. 3, (a x R1)Fl cold targets were as effective as parental _a cold targets at
blocking the lysis of "Cr-labeled _a targets by c anti-a CTL. (c x a)F1 cold targets,
which expressed heterozygous levels of Aa+, were considerably less effective com-
petitors (data not shown).
The second line of evidence for the expression of homozygous levels of Aa+ ex-
pression on (a x R1)Fj cells came from the behavior of the mAbJY3/84. This an-
tibody is one of alarge number of mAbs raised against the Aa molecule (20). When
tested for their binding to parental a and recombinant RBC, all these antibodies
gave a higher bindinglevel on _a than on Rl or the other recombinants, reflecting
a previously noted quantitative difference in antigen expression associated with the
recombinant haplotypes (30, 31). In the case ofJY3/84, however, bindingto R1 was
abnormally poor in comparison with parental a; indeed, it was scarcely detectable
in some experiments. It appeared that JY3/84 detected a qualitative difference be-
tween the RTLAa molecules expressed on parental a and recombinant cells. We ex-
amined the binding of this antibody to erythrocytes from a panel of inbred strains
and F1 hybrids (Table II). (a x Rl)Fi cells bound about the same number of counts
as parental a cells, which expressed homozygous levels of Aa+; this was consider-
ably greater than the counts bound by (a x c)F1 cells, which expressed heterozy-
gous levels of Aa+. The amount of JY3/84 bound to R1 and (c x R1)F1 cells was
scarcely above background.
Demonstration of a trans-acting Modification of the RTI.Aa Class IMolecule by Complemen-
tation in FI Hybrids. The binding assay shown in Table II includes data from a
number of Fl hybrids made between Rl and various inbred strains. Erythrocytes
from two of these Fl hybrids, (1(AGUS) x R1)Fl and (1(F344) x Rl)F1, bound
about the same amount ofJY3/84 as (a x c)Fi erythrocytes, although JY3/84 did
not bind to homozygous 1(AGUS) or 1(F344) cells. The reactivity ofcells from (1 x
RI)Fi donors with mAbJY3/84 suggested that these heterozygotes were expressingU
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TABLE II
Binding of mAb JY3184 to Aa on RBC from
Various Rat Strains and Hybrids
Data are means of triplicate determinations ( + / - SD).
" All rats are congenic on the PVG background (see Table I).
Not included in this experiment, but no binding ofJY3/84 above background
seen in several other experiments .
Aa+ at heterozygous levels and not the expected Aa- . We tested this directly by using
Con A blasts from these rats as targets for (c x a)F1 anti-R1 CTL, specific for the
Aa- form of the antigen. Fig. 8 shows that there was no significant lysis of these
target cells; the control (c x R1)F1 and (u x R1)F1 targets were lysed quite effec-
tively, showing that heterozygous levels of Aa- expression were detectable in this
assay.
F
U
X O
O
U
so
so
io
0
EFFECTOR : TARGET RATIO
FIGURE 8. (I x Rl)FI cells express no detectable Aa-.
CTL specific for the Aa- form of the Aa class I molecule,
generated in the combination (c x a)FI anti-RI, were as-
sayed on a panel of target cells.
Rat Anti-Ig bound
Anti-Ig bound
without JY3/84
cpm cpm
a" 1,659 (65) 67 (1)
R1 158 (19) 39 (9)
(a x R1)Fl 1,488 (428) 66 (12)
c -
(a x c)FI 502 (28) 54 (20)
(c x R1)F 154 (19) 43 (2)
1(F344) 50 (9) 36 (10)
(1(F344) x Rl)FI 832 (78) 66 (11)
1(AGUS) 46 (7) 46 (9)
(1(AGUS) x R1)FI 731 (18) 58 (7)LIVINGSTONE ET AL .
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FIGURE 9.
￿
Two-dimensional peptic peptidemaps of RTLA'H chains precipitated from _a and
Rl lymphoid cells by theRT1.Aa-specific mAb, R3/13 . Tyrosine peptides were labeled with 125I .
Autoradiographic exposure, 10 d .
This experiment proved that the expression of Aa- was determined by a trans-
interaction between the RTLAI region and the dominant allele of a locus, which,
in the a haplotype, mapped to the right of the RT1.A/RT1.B recombination site(s) .
The dominant allele at this locus is carried by thea and lhaplotypes, while a reces-
sive (possibly null) allele is carried by the c and u haplotypes. We have named this
locus cim (for classImodification), and suggest that the dominant allele be called cim°
and the recessive or null allele cimb .
No Differences Observed betweenAa' andAa- on Two-dimensional Peptic PeptideMaps .
￿
Aa
class I moleculeswere immunoprecipitated from detergent lysatesoflactoperoxidase-
iodinated a and R1 Con A blasts using the Aa-specific mAb R3/13 conjugated to
Sepharose 4B . Two-dimensional peptic peptide maps were prepared of the heavy
(46-kD) polypeptide as described elsewhere (22) . No differential peptides were seen
in several comparisons (Fig. 9) ; in contrast, RTLA class I polypeptides from eight
different major haplotypes tested showed striking differences (22) .
Patterns ofBiosynthetic Intermediates ofAa differ in a andRI Cells.
￿
Although the pre-
vious analysis showed no difference in peptide structure between the parental and
recombinant forms of Aa, examination of the biosynthesis of the antigen using
pulse-chase studies of internally labeled ConA blasts clearly indicated a difference
in the processing rates of the two forms of the antigen (Fig. 10). In parental a cells
the increase in molecular weight corresponding to the fully mature Aa+ antigen was
observed to begin -30 min post-pulse. All the labeled material had progressed into790
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FIGURE 10 .
￿
Pulse-chase experiment demonstrating biosynthesis ofAa in parental (a)andrecom-
binant (RI) ConA blasts. After incorporation of 35S-methionine and cold chase for the indi-
cated times, lysed cells were immunoprecipitated with R3/13-Sepharose . Apparent molecular
weights are kilodaltons, SDS-PAGE was performed on an 11% gel, and fluorography was per-
formed for 7 d at -70°C .
the upper molecular weight form by 120 min . By contrast, in R1, the Aa- antigen
remained in the lower form for amuch greaterlength of time, with little indication
ofthe upperform appearing even after 120 min . The pattern seen for the processing
ofAa, corresponded well with that previously reported for both H-2 andHLA class
I antigens (32-34).
Discussion
We describe in this paper the discovery of an MHC-linked locus, cim, that con-
trols the structural modification ofa rat class I major transplantation antigen . ThisLIVINGSTONE ET AL.
￿
791
locus influences the antigenic structure of the RT1.Aa class I molecule (Aa), but
maps outside the RTLA region. It appears to have at least two alleles: a dominant
allele, cima, and a recessive or null allele, cimb, determining two alternative forms
of the Aa molecule, Aa+ and Aa-, respectively. From an immunological standpoint,
the antigenic difference between the two forms is reminiscent of that seen between
wild type and the stronger mutant forms of the mouse H-2Kb class I molecule,
beingreadily demonstrated with both alloreactive CTL (including primary in vitro
responses) and MHC-restricted CTL, but more difficult to detect serologically (35,
36). Experimental results presentedelsewhere (37) may nowbe interpreted to sug-
gest that antigenicdifferences controlled by this locus determine the rejection of lym-
phoid grafts, butso farthere is no evidence for rejection of skin grafts (unpublished
results). The structural basis for this antigenic difference is yet to be determined,
but thegeneticcontrolofthe system andpreliminarybiochemicaldata showinganom-
alous glycan processing in cimb homozygotes exclude some possible explanations for
the findings and suggest others.
It is unlikely that the antigenic difference between Aa+ andAa- is due to adiffer-
ence in the primary sequence of the Aa product since the expression of Aa+ can be
complemented in trans by crossing a cimb haplotype expressing Aa-, such as RTlrl
(see Table I), with the cim° haplotype RT1', which does not itself contain the Aa al-
lele. Thus, the Aa gene is expressed as Aa+ or Aa- forms, depending only on the
identity of the allele at the cim locus. Other interpretations, in which the cim locus
product determines alternative splice forms of RT1.Aa, or conceivably even regu-
lates the expression of similar but distinct structural genes coding forAa+ and Aa-,
are constrained by the evidence presented in Fig. 9 showing identicalpeptide maps
for Aa+ and Aa-. Such interpretations are, however, now amenable to direct ex-
perimental test, since the RTLAa classical gene product has recently been cloned
and expressed as a cDNA (Rada, C., R. Lorenzi, S. Powis, J. van den Bogaerde,
P Parham, and J. C. Howard, manuscript in preparation).
The antigenic difference between Aa+ and Aa- is clearly connected in some way
with the anomalous post-translational processing of the Aa- form of antigen. The
increase in molecular weight of the Aa+ product after a 30-45-min chase period is
consistent with the typical biosynthetic behavior of H-2 and HLA class I molecules
(32-34), and is attributed to the shift from high mannose to complex-type glycans,
and to terminal sialylation during traffic through theGolgi (32-34). Recent evidence
is consistent with this interpretation, and suggests that the persistent low molecular
weight Aa- form retains the high mannose type glycan for a prolonged period (un-
published results). It may be relevant to this observation that the Aa- form of an-
tigen is knownto be relatively underexpressedon the surface ofrestinglymphocytes
and erythrocytes (30, 31).
It is possible that the cim product is an enzyme directly involved in glycan
modification. There is already evidence for both glycosidase and glycosyl transferase
activity mapping to the MHC. The best characterized of these loci is Neu-1, map-
ping in H-2 between E and D (38-40). This locus specifies a neuraminidase whose
known action is to modify the processing of several enzymes, including a mannosi-
dase expressed in the liver and in lymphocytes (40). An equivalent activity hasbeen
mapped to the rat MHC (41), but notyet located as to region. The critical question,
however, is whether the differential post-translational modification of Aa+ and Aa-
is directly responsible for the different antigenic specificity the two forms present792
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at the cell surface. It must be emphasized that there is, as yet, no evidence for dis-
tinct glycan structures on the membrane forms of Aa+ and Aa- . Furthermore, de-
spite earlierclaims (42, 43), it has been difficult to find either sugar-definedor sugar-
modified T cell or antibody epitopes on classical class I molecules in several well-
analyzed systems (44-46).
There is, however, a precedent involving the mouse nonclassical class I molecule,
Qa-1, that may be relevant to the present findings. Qa-1 has been reported to occur
in a number of allelic forms, as detected by CTL, some at least of which appear
to be dependent on normal N-linked glycosylation (47). Furthermore, it has recently
been shown that Qa-1, like Aa, is subject to structural modification by the product
of a trams-dominant MHC-linked gene mapping to the H-2D region (48). It will there-
fore be of interest to know whether anomalous post-translational processing as de-
scribed in the present report also occurs in the Qa-1 system.
If glycan modification by thecim system is indeed responsible forourown findings,
it will be important to discover why, in this case, the effect on T cell recognition
is so marked. Crystallographic data for the human classical class I molecule, HLA-
A2, suggest that the single N-linked glycan on thefirst domain may be oriented away
from the presumed peptide-binding and TCR interaction region (49), a result con-
sistent with the general failure to find significant dependence of T cell specificity
on glycans. RTIAa alone among known classical class I sequences has N-linked
glycosylation signal sequenceson thefirstandthirddomains(Rada, C., R. Lorenzi, S.
Powis, J. van den Bogaerde, P. Parham, andJ. C. Howard, manuscript in prepara-
tion). Conceivably this unusual arrangement of glycans could be subject to struc-
tural modification via the cim system and could in turn transmit a structural altera-
tion to the peptide-binding cleft. Such an effect might be expected to have the kind
of large scale antigenic consequences reported here.
We should finally consider the possibility that the primary action of cim is not
on glycan modification as such, but rather on the ability of RTIAa molecules to pro-
ceed normally through intracellular processing. The result of the pulse-chase study
shown in Fig. 10 would be consistent with the possibility that the
Aa- form is re-
tained for an abnormally long time in the endoplasmic reticulum or early Golgi,
while the presence of the dominant cima product releases this inhibition of trans-
port. Recent experiments suggest that polymorphic sequences of the Aa molecule
itselfcontribute to its sensitivity to the cim phenomemon, since classical class I mol-
ecules other than Aa from cimb strains seem to be processed with normal kinetics
(unpublished results). It is not clear how retention of RTIAa in an earlybiosynthetic
compartment might affect the antigenic activity of those molecules that do reach
the membrane. However, since class I molecules may be loaded with endogenous
peptides during assembly, the possibility that the cim product may be involved in
some allele-specific way with the loading process is worth considering.
Mapping of the cim locus within the MHC is presently in progress. Preliminary
results suggest that the locus maps between RTIA and RTlD (see Fig. 1) and it is
therefore unlikely that thecimlocuswill prove to be identical to theH-2D region-linked
Qa-1-modifying locus (48) referred to above. In view of the fact that the whole re-
gion homologous to the RTIA-RTID interval has been cloned in the mouse (29)
and much of it also cloned in the RTla and RTl` haplotypes of the rat (50), it is
likely that the molecular identity of the cim product will soon be known.LIVINGSTONE ET AL.
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Summary
The RTLA locus of the rat MHC encodes the H chain of the single classical class
I molecule of this species. One of the alleles of this polymorphic locus, RT1.Aa, is
present in several laboratory inbred, congenic, and MHC recombinant rat strains.
Studies of the RT1.Aa class I molecule from a number of these strains as a target
for CTL show that its antigenicity, both as an alloantigen and a restricting element,
is subject to gain and loss alterations by the action of a gene mapping in the MHC
to the right ofRTLA. This locus is apparently present in two allelic forms (one pos-
sibly a null allele) corresponding to the presence or absence of a dominant trans-
acting modifier, and has been named class1 modification, orcim. The antigenic change
brought about by cim is scarcely detectable serologically but highly immunogenic
for CTL. Biochemical investigations show that cim affects the post-translational
modification of RT1.Aa.
We thank our colleagues Drs. Nick Holmes, PatJones, Peter Parham, and Prim Singh for
critical reviews of the manuscript, and Julia Goddard, Joan Payne, and Jenny Richards for
preparing the manuscript for publication.
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